These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 25482272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance.
    Ruohonen ST, Pesonen U, Moritz N, Kaipio K, Röyttä M, Koulu M, Savontaus E.
    Diabetes; 2008 Jun; 57(6):1517-25. PubMed ID: 18276767
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y in noradrenergic neurons induces obesity in transgenic mouse models.
    Vähätalo LH, Ruohonen ST, Ailanen L, Savontaus E.
    Neuropeptides; 2016 Feb; 55():31-7. PubMed ID: 26681068
    [Abstract] [Full Text] [Related]

  • 4. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.
    Ailanen L, Ruohonen ST, Vähätalo LH, Tuomainen K, Eerola K, Salomäki-Myftari H, Röyttä M, Laiho A, Ahotupa M, Gylling H, Savontaus E.
    J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice.
    Nguyen AD, Slack K, Schwarzer C, Lee NJ, Boey D, Macia L, Yulyaningsih E, Enriquez RF, Zhang L, Lin S, Shi YC, Baldock PA, Herzog H, Sainsbury A.
    Neuropeptides; 2014 Jun; 48(3):143-51. PubMed ID: 24680736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L, Lee NJ, Nguyen AD, Enriquez RF, Riepler SJ, Stehrer B, Yulyaningsih E, Lin S, Shi YC, Baldock PA, Herzog H, Sainsbury A.
    Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y.
    Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW.
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1680-8. PubMed ID: 11753591
    [Abstract] [Full Text] [Related]

  • 19. p38α function in osteoblasts influences adipose tissue homeostasis.
    Rodríguez-Carballo E, Gámez B, Méndez-Lucas A, Sánchez-Freutrie M, Zorzano A, Bartrons R, Alcántara S, Perales JC, Ventura F.
    FASEB J; 2015 Apr; 29(4):1414-25. PubMed ID: 25550462
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis.
    Tomaszuk A, Simpson C, Williams G.
    Horm Res; 1996 Apr; 46(2):53-8. PubMed ID: 8871182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.